4.8 Article

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Anika Singanayagam et al.

Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.

LANCET INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

R. L. Gottlieb et al.

Summary: In symptomatic, nonhospitalized high-risk Covid-19 patients, a 3-day course of remdesivir significantly reduced the risk of hospitalization or death compared to placebo, with acceptable safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Cell Biology

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer et al.

Summary: In a clinical trial, the safety, tolerability, and antiviral efficacy of molnupiravir were evaluated in unvaccinated individuals with confirmed SARS-CoV-2 infection. The study found that participants receiving high-dose molnupiravir had a shorter time to viral RNA clearance and a lower detection rate of infectious virus. Molnupiravir was well tolerated across all doses.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19)

Stephanie Baggio et al.

Summary: The study found that there were no significant differences in SARS-CoV-2 RNA loads between children and adults in the early stages of COVID-19.

CLINICAL INFECTIOUS DISEASES (2021)

Review Virology

Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis

Jingjing He et al.

Summary: Approximately 15.6% of confirmed COVID-19 patients are asymptomatic. Nearly half of the patients with no symptoms at detection time will develop symptoms later. Children are likely to have a higher proportion of asymptomatic infection than adults. Asymptomatic COVID-19 patients could have abnormal laboratory and radiational manifestations, which can be used as screening strategies to identify asymptomatic infection.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Immunology

Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers

Myron M. Levine et al.

Summary: The World Health Organization formed an Advisory Group to discuss the feasibility, potential value, and limitations of establishing a closely-monitored challenge model of SARS-CoV-2 infection and COVID-19 in healthy adult volunteers. The report highlights the challenges in setting up a COVID-19 model and suggests prudent strategies for model development, challenge virus selection, and containment measures. While a COVID-19 model may demonstrate protection against illness induced by prior SARS-CoV-2 challenge or vaccination, its limitations include the inability to directly predict vaccine efficacy in elderly or high-risk adults based on experiments with young healthy adults.

CLINICAL INFECTIOUS DISEASES (2021)

Article Clinical Neurology

Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection

Rafal Butowt et al.

Summary: The prevalence of smell and taste dysfunction in COVID-19 differs between populations, possibly due to differences in virus strains or host proteins. Recent progress has been made in defining the cellular and molecular mechanisms of virus-induced anosmia, focusing on the role of sustentacular cells in the olfactory epithelium. The potential for using smell and taste dysfunctions as early diagnostic tools in COVID-19 is discussed.

NEUROSCIENTIST (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Article Public, Environmental & Occupational Health

Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study

Billy J. Quilty et al.

Summary: The study suggests that testing contacts and reducing quarantine duration can be effective in limiting onward transmission of COVID-19, with potential for substantial reduction in the length of quarantine with a small excess in transmission risk. Adherence to quarantine and self-isolation, along with decreasing test and trace delays, are key factors in improving the effectiveness of these strategies. Further research is needed to evaluate the costs and benefits of implementing such strategies as policy.

LANCET PUBLIC HEALTH (2021)

Review Public, Environmental & Occupational Health

Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis

Gopiram Syangtan et al.

Summary: Asymptomatic cases of SARS-CoV-2 play a crucial role in magnifying the transmission of COVID-19, with children and females more likely to present as asymptomatic cases. Therefore, establishing a mass surveillance system to track potential asymptomatic cases is essential, with special attention to females and children.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Respiratory System

Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients

Dieter Munker et al.

Summary: The study found that upon admission to the hospital, there was no significant difference in viral shedding between severe and nonsevere COVID-19 cases. However, in the second week of hospitalization, severely ill patients showed elevated viral shedding and a prolonged inflammatory response, which were associated with a more severe disease course.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2

Matan Levine-Tiefenbrun et al.

Summary: The study found that the effectiveness of the BNT162b2 vaccine in reducing viral loads of breakthrough infections decreases over time. However, this reduction in viral load can be restored by receiving a third vaccine dose.

NATURE MEDICINE (2021)

Article Infectious Diseases

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Michael Marks et al.

Summary: The viral load of index cases is a key driver of SARS-CoV-2 transmission, while the viral load of contacts at baseline is strongly associated with the risk of developing symptomatic COVID-19 and shortening the incubation period in a dose-dependent manner.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness

Ruian Ke et al.

Summary: The study developed viral dynamic models of SARS-CoV-2 infection and established a model linking viral load (VL) to infectiousness. The analysis showed that VL in the upper respiratory tract is a better surrogate of infectiousness. Furthermore, RT-PCR tests performed better in detecting infection and preventing transmission, but more frequent antigen testing could provide similar results at a lower cost.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Letter Medicine, General & Internal

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19

Min-Chul Kim et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Public, Environmental & Occupational Health

Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus

Irene Petersen et al.

Summary: The testing for SARS-CoV-2 internationally has largely been focused on COVID-19 diagnosis through PCR tests among symptomatic individuals, but there has been a recent shift towards using LFT for testing asymptomatic individuals in public health programs. By recalibrating relative performance statistics, the sensitivity of LFT for detecting individuals shedding SARS-CoV-2 antigens can be significantly improved.

CLINICAL EPIDEMIOLOGY (2021)

Article Critical Care Medicine

Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza A Clinical Study

Suzanna Paterson et al.

Summary: The study highlighted the suboptimal vaccine immunogenicity, antigenic mismatch, and poor uptake leading to influenza remaining a major global disease. Investigating the kinetics, phenotypes, and function of influenza virus-specific CD8(+) resident memory T cells in the lower airway, it was found that CD8(+) Trm cells in the human lung display innate-like gene and protein expression that demonstrates blurred divisions between innate and adaptive immunity.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Medicine, General & Internal

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 A Randomized Trial

Andreas Barratt-Due et al.

Summary: A randomized controlled trial conducted in 23 hospitals in Norway found that remdesivir and hydroxychloroquine did not affect viral clearance in hospitalized COVID-19 patients. There was also no impact on mortality, degree of respiratory failure, or inflammatory variables.

ANNALS OF INTERNAL MEDICINE (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic

Garth Rapeport et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

S. J. Thomas et al.

Summary: BNT162b2 vaccine remains highly effective and safe over the course of 6 months post-vaccination, with efficacy rates ranging from 86% to 100% across different demographics and risk factors for Covid-19. The vaccine also shows a high efficacy against severe disease, with particularly promising results observed in South Africa against the B.1.351 variant.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters

Rana Abdelnabi et al.

Summary: The global COVID-19 pandemic has resulted in over 108 million infections and 2.4 million deaths within a year, with new variants of concern emerging. Research on prototypic VoC from B.1.1.7 and B.1.351 variants in hamsters revealed efficient infection of the lower respiratory tract and highlighted the need for assessing vaccine and therapeutic efficacy against these variants.

EBIOMEDICINE (2021)

Letter Medicine, General & Internal

Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis

Marion Renaud et al.

Summary: This cohort study examines the clinical course and prognosis of patients with COVID-19-related anosmia for 1 year after diagnosis.

JAMA NETWORK OPEN (2021)

Letter Medicine, General & Internal

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Lirong Zou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Yixuan J. Hou et al.

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Temporal dynamics in viral shedding and transmissibility of COVID-19

Xi He et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation

D. Gbesemete et al.

BMC MEDICINE (2020)

Article Multidisciplinary Sciences

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Brandi N. Williamson et al.

NATURE (2020)

Editorial Material Medicine, General & Internal

Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models

Meagan E. Deming et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Infectious Diseases

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Kieran A. Walsh et al.

JOURNAL OF INFECTION (2020)

Article Multidisciplinary Sciences

Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection

Maximillian S. Habibi et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Jesse Fajnzylber et al.

NATURE COMMUNICATIONS (2020)

Article Immunology

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

Kyle Rosenke et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Critical Care Medicine

Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

John P. DeVincenzo et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)